Menu

Seelos Therapeutics, Inc. SEEL

Full chart Compare
Set alert

Price alert · SEEL

All alert types
0.37 USD +0.37

Day range unavailable

52-week range unavailable

YTD
-71.09%
1 year
-71.09%

Revenue & Expenses

Other Income → Expenses: $2.69MExpenses → Selling, General & Admin: $12.59MExpenses → Research & Development: $30.12MExpenses → Interest Expense: $75.00KGross Profit → Expenses: $2.20MRevenue → Gross Profit: $2.20MNet Loss → Expenses: $37.88MOther Income$2.69MGross Profit$2.20MNet Loss$37.88MExpenses$42.78MSelling, General & Admin$12.59MResearch & Development$30.12MInterest Expense$75.00KRevenue$2.20M

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

SEEL annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.20M000375.00K
2.20M000375.00K
2.20M000375.00K
42.70M70.92M61.67M18.76M30.12M
30.12M58.62M46.65M10.98M22.56M
12.59M12.30M15.02M7.78M7.56M
-40.50M-70.92M-61.67M-18.76M-29.75M
75.00K14.00K1.60M164.00K29.00K
-37.88M-73.53M-66.05M-19.10M-51.26M
-37.88M-73.53M-66.05M-19.10M-51.26M
-37.88M-73.53M-66.05M-19.10M-51.26M
-37.88M-73.53M-66.05M-19.10M-51.26M
-61.84-165.92-175.20-103.20-604.80
-61.84-165.92-175.20-103.20-604.80
-61.84-165.92-175.20-103.20-604.80
-37.81M-73.52M-64.45M-18.94M-51.23M
-37.81M-73.52M-64.45M-18.94M-51.23M
612.53K443.21K378.71K186.53K84.62K
612.53K443.21K378.71K186.53K84.62K